(Q47876324)

6 February 2018

title

A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis (English)

1 reference

6 February 2018

0 references

5

Gregory J Gores

1 reference

6 February 2018

author name string

K V Narayanan Menon

1

1 reference

6 February 2018

Linda Stadheim

2

1 reference

6 February 2018

Patrick S Kamath

3

1 reference

6 February 2018

Russell H Wiesner

4

1 reference

6 February 2018

Craig J Peine

6

1 reference

6 February 2018

Vijay Shah

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 February 2018

The American Journal of Gastroenterology

published in

1 reference

6 February 2018

volume

99

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

255-260

1 reference

6 February 2018

The treatment of alcoholic hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

A model to predict survival in patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Experience with etanercept in an academic medical center: are infection rates increased?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

The tumor necrosis factor ligand and receptor families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Immune function in patients with rheumatoid arthritis treated with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Viral pneumonia as a serious complication of etanercept therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.04034.X

10.1111/J.1572-0241.2004.04034.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018